Richard D. Weisel | Academic Influence

Why Is Richard D. Weisel Influential?

Richard D. Weisel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients (1994) (3667)
Autologous transplantation of bone marrow cells improves damaged heart function. (1999) (1100)
A Self-Fulfilling Prophecy: C-Reactive Protein Attenuates Nitric Oxide Production and Inhibits Angiogenesis (2002) (1095)
New Markers of Inflammation and Endothelial Cell Activation: Part I (2003) (783)
Guidelines for reporting morbidity and mortality after cardiac valvular operations. (1988) (763)
Clinical and Pathophysiological Implications of a Bicuspid Aortic Valve (2002) (729)
Resistin Promotes Endothelial Cell Activation: Further Evidence of Adipokine-Endothelial Interaction (2003) (677)
Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein (2002) (659)
Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. (2016) (610)
C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and Function: Further Evidence of a Mechanistic Link Between C-Reactive Protein and Cardiovascular Disease (2004) (573)
C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle (2003) (557)
Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. (2006) (539)
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. (2016) (530)
Guidelines for reporting morbidity and mortality after cardiac valvular operations. (1996) (516)
Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. (2003) (452)
Deep sternal wound infection: risk factors and outcomes. (1998) (428)
Fundamentals of reperfusion injury for the clinical cardiologist. (2002) (411)
Cardiomyocyte transplantation improves heart function. (1996) (389)
Guidelines for reporting morbidity and mortality after cardiac valvular operations. (1996) (387)
Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. (2002) (357)
Survival and function of bioengineered cardiac grafts. (1999) (349)
Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair (2010) (329)
Endothelial progenitor cells: new hope for a broken heart. (2003) (295)
Predictors of low cardiac output syndrome after coronary artery bypass. (1996) (269)
Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery. (2016) (255)
Mechanical Stretch Regimen Enhances the Formation of Bioengineered Autologous Cardiac Muscle Grafts (2002) (250)
Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. (2008) (239)
Smooth muscle cell transplantation into myocardial scar tissue improves heart function. (1999) (238)
Biomarkers of Vascular Disease Linking Inflammation to Endothelial Activation: Part II (2003) (234)
Consequences of postoperative alterations in respiratory mechanics. (1974) (231)
Technique of successful clinical double-lung transplantation. (1988) (222)
Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. (1997) (222)
Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. (2011) (219)
Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. (1996) (215)
Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. (1986) (212)
The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes. (2014) (211)
Construction of a bioengineered cardiac graft. (2000) (200)
Measurement of Cardiac Output by Thermodilution (1975) (199)
Coronary artery bypass grafting in patients with poor ventricular function (1992) (191)
TIMP-3 Deficiency Leads to Dilated Cardiomyopathy (2004) (187)
Neuropsychologic impairment after coronary bypass surgery: effect of gaseous microemboli during perfusionist interventions. (2001) (179)
Myocardial depression during sepsis. (1977) (178)
Fifteen-year trends in risk severity and operative mortality in elderly patients undergoing coronary artery bypass graft surgery. (1998) (173)
Rosiglitazone Facilitates Angiogenic Progenitor Cell Differentiation Toward Endothelial Lineage: A New Paradigm in Glitazone Pleiotropy (2004) (167)
A clinical trial of blood and crystalloid cardioplegia. (1984) (166)
Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. (2000) (163)
Natural history of fetal rat cardiomyocytes transplanted into adult rat myocardial scar tissue. (1997) (162)
Coronary bypass and carotid endarterectomy: does a combined approach increase risk? A metaanalysis. (1999) (162)
Mueller matrix decomposition for polarized light assessment of biological tissues (2009) (157)
Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel. (2011) (156)
The changing pattern of coronary artery bypass surgery. (1989) (155)
Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia. (1994) (154)
Is Blood Superior to Crystalloid Cardioplegia?: A Meta-Analysis of Randomized Clinical Trials (2006) (153)
In vivo survival and function of transplanted rat cardiomyocytes. (1996) (151)
Fetal cell transplantation: a comparison of three cell types. (1999) (144)
Optimal Biomaterial for Creation of Autologous Cardiac Grafts (2002) (142)
Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. (2001) (141)
Is body size the cause for poor outcomes of coronary artery bypass operations in women? (1995) (138)
The changing pattern of reoperative coronary surgery: trends in 1230 consecutive reoperations. (2000) (136)
A Conductive Polymer Hydrogel Supports Cell Electrical Signaling and Improves Cardiac Function After Implantation into Myocardial Infarct (2015) (134)
Cardiac remodeling and failure From molecules to man (Part II). (2005) (134)
Myocardial metabolism and ventricular function following cold potassium cardioplegia. (1985) (133)
Sleeve lobectomy for carcinoma of the lung. (1979) (133)
A comparison of the late patency rates of axillobilateral femoral and axillounilateral femoral grafts. (1977) (126)
Inadequate myocardial protection with cold cardioplegic arrest during repair of tetralogy of Fallot. (1988) (122)
Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice. (2009) (121)
Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. (2005) (120)
Limitations of blood conservation. (1984) (119)
Identification of oxygen responsive elements in the 5'-flanking region of the human glutathione peroxidase gene. (1993) (117)
Enhanced Myocardial Angiogenesis by Gene Transfer With Transplanted Cells (2001) (117)
The cytoprotective effect of Trolox demonstrated with three types of human cells. (1990) (117)
Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair. (2011) (115)
Autologous heart cell transplantation improves cardiac function after myocardial injury. (1999) (114)
Stroke during coronary bypass surgery: principal role of cerebral macroemboli. (2001) (113)
Effect of sodium tanshinone IIA sulfonate in the rabbit myocardium and on human cardiomyocytes and vascular endothelial cells. (1993) (112)
Myocardial free-radical injury after cardioplegia. (1989) (111)
Inaccurate and misleading valve sizing: a proposed standard for valve size nomenclature. (1998) (110)
Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3. (2003) (110)
The fate of a tissue-engineered cardiac graft in the right ventricular outflow tract of the rat. (2001) (105)
C-Reactive Protein Upregulates Complement-Inhibitory Factors in Endothelial Cells (2004) (105)
Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor. (2005) (104)
Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery. (2009) (104)
Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. (1996) (104)
Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions. (1999) (103)
Cardiac remodeling and failure: from molecules to man (Part III). (2005) (103)
Results of combined pulmonary resection and cardiac operation. (1996) (102)
Heart Cell Transplantation Improves Heart Function in Dilated Cardiomyopathic Hamsters (2000) (102)
Adenosine myocardial protection: preliminary results of a phase II clinical trial. (1999) (102)
Valvular surgery in the elderly. (1989) (100)
Altered Expression of Disintegrin Metalloproteinases and Their Inhibitor in Human Dilated Cardiomyopathy (2006) (99)
Autologous smooth muscle cell transplantation improved heart function in dilated cardiomyopathy. (2000) (99)
Coronary artery bypass grafting in patients with poor ventricular function. Cardiovascular Surgeons of the University of Toronto. (1992) (98)
Myocardial salvage with trolox and ascorbic acid for an acute evolving infarction. (1989) (98)
Polypyrrole-chitosan conductive biomaterial synchronizes cardiomyocyte contraction and improves myocardial electrical impulse propagation (2018) (96)
Improved Left Ventricular Aneurysm Repair With Bioengineered Vascular Smooth Muscle Grafts (2003) (96)
C-reactive protein activates the nuclear factor-kappaB signal transduction pathway in saphenous vein endothelial cells: implications for atherosclerosis and restenosis. (2003) (96)
Ventricular function after normothermic versus hypothermic cardioplegia. (1993) (95)
Prevention of postbypass bleeding with tranexamic acid and ϵ-aminocaproic acid (1993) (94)
Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. (1996) (94)
Coronary artery bypass grafting in patients with non-dialysis-dependent renal insufficiency. (1997) (93)
Assessment of myocardial performance and optimal volume loading during elective abdominal aortic aneurysm resection. (1977) (92)
Relation between aortic cross-clamp time and mortality--not as straightforward as expected. (2008) (91)
Prevention and management of deep sternal wound infection. (2004) (91)
Intravenously Administered Bone Marrow Cells Migrate to Damaged Brain Tissue and Improve Neural Function in Ischemic Rats (2007) (90)
Polarization birefringence measurements for characterizing the myocardium, including healthy, infarcted, and stem-cell-regenerated tissues. (2010) (89)
Aging impairs the angiogenic response to ischemic injury and the activity of implanted cells: combined consequences for cell therapy in older recipients. (2010) (89)
Role of miR-145 in cardiac myofibroblast differentiation. (2014) (88)
Histologic changes of nonbiodegradable and biodegradable biomaterials used to repair right ventricular heart defects in rats. (2002) (87)
The effect of warm heart surgery on postoperative bleeding. (1992) (86)
Maximizing Ventricular Function With Multimodal Cell-Based Gene Therapy (2005) (85)
Intraoperative myocardial protection: current trends and future perspectives. (1999) (84)
Effect of oxygen tension and cardiovascular operations on the myocardial antioxidant enzyme activities in patients with tetralogy of Fallot and aorta-coronary bypass. (1992) (84)
Comparison between antibiotic irrigation and mobilization of pectoral muscle flaps in treatment of deep sternal infections. (1985) (84)
Stem Cell Factor Deficiency Is Vasculoprotective: Unraveling a New Therapeutic Potential of Imatinib Mesylate (2006) (83)
Predictors of operative risk for coronary bypass operations in patients with left ventricular dysfunction. (1999) (81)
Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C. (1997) (80)
Predictors of operative survival after valve replacement. (1988) (80)
The optimal cardioplegic temperature. (1994) (80)
Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery. (2001) (80)
Comparison of conduits for leg revascularization. (1981) (80)
Should radial arteries be used routinely for coronary artery bypass grafting? (2004) (78)
Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering (2011) (77)
Right ventricular dysfunction following cold potassium cardioplegia. (1985) (77)
Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass. (1988) (76)
Tepid antegrade and retrograde cardioplegia. (1995) (76)
Cardiac remodeling and failure: from molecules to man (Part I). (2005) (75)
c-Kit Dysfunction Impairs Myocardial Healing After Infarction (2007) (74)
Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelin antagonism. (2002) (73)
Angiogenesis by endothelial cell transplantation. (2001) (73)
Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial (2019) (73)
Increasing transplanted cell survival with cell-based angiogenic gene therapy. (2005) (73)
Culture of rat endometrial telocytes (2012) (73)
Beneficial effect of autologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cells. (2003) (73)
Stem cells and regenerative medicine - future perspectives. (2012) (72)
Activation of c‐kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury (2008) (72)
Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia. (1998) (72)
Effects of postoperative hypertension and its treatment. (1983) (71)
Bicuspid aortic valve disease: recent insights in pathophysiology and treatment (2005) (71)
Pulmonary vein stenosis and the pathophysiology of "upstream" pulmonary veins. (2014) (70)
Risk Factors for Stroke Following Coronary Bypass Surgery (1995) (70)
Optimal delivery of blood cardioplegia. (1991) (70)
Alternative Techniques of Cardioplegia (1992) (70)
Increased risk of urgent revascularization. (1987) (69)
Elastin Stabilizes an Infarct and Preserves Ventricular Function (2005) (69)
Glitazones and heart failure: critical appraisal for the clinician. (2003) (69)
Targeted myocardial delivery of GDF11 gene rejuvenates the aged mouse heart and enhances myocardial regeneration after ischemia–reperfusion injury (2016) (67)
The use of cationic microbubbles to improve ultrasound-targeted gene delivery to the ischemic myocardium. (2013) (66)
Vitamin E for coronary bypass operations. A prospective, double-blind, randomized trial. (1994) (66)
Decreased cerebral emboli during distal aortic arch cannulation: a randomized clinical trial. (1999) (66)
Permanent Cardiac Pacing After Open‐heart Surgery: Acquired Heart Disease (1984) (65)
Human pediatric and adult ventricular cardiomyocytes in culture: assessment of phenotypic changes with passaging. (1996) (65)
Elevated insulin-like growth factor-I and transforming growth factor-beta 1 and their receptors in patients with idiopathic hypertrophic obstructive cardiomyopathy. A possible mechanism. (1998) (64)
Preserving Prostaglandin E2 Level Prevents Rejection of Implanted Allogeneic Mesenchymal Stem Cells and Restores Postinfarction Ventricular Function (2013) (64)
Morbidity and mortality in mitral valve surgery. (1985) (63)
Quantitative analysis of survival of transplanted smooth muscle cells with real-time polymerase chain reaction. (2005) (63)
Cerebral microemboli during cardiopulmonary bypass: Increased emboli during perfusionist interventions (2000) (61)
Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats. (2008) (61)
Stem Cell Factor Attenuates Vascular Smooth Muscle Apoptosis and Increases Intimal Hyperplasia After Vascular Injury (2007) (61)
Which techniques of cardioplegia prevent ischemia? (1993) (61)
Sepsis presenting as acute respiratory insufficiency. (1974) (59)
Skeletal Myoblasts Preserve Remote Matrix Architecture and Global Function When Implanted Early or Late After Coronary Ligation Into Infarcted or Remote Myocardium (2008) (59)
Hyperglycemia potentiates the proatherogenic effects of C-reactive protein: reversal with rosiglitazone. (2003) (57)
TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction. (2007) (57)
Aortic valve replacement with a small prosthesis. (1987) (57)
VEGF-loaded microsphere patch for local protein delivery to the ischemic heart. (2016) (56)
Myocardial performance after repair of congenital cardiac defects in infants and children. Response to volume loading. (1988) (56)
The regulation of glutathione peroxidase gene expression by oxygen tension in cultured human cardiomyocytes. (1992) (56)
Effect of oxygen tension on the anti-oxidant enzyme activities of tetralogy of Fallot ventricular myocytes. (1989) (55)
Cellular senescence contributes to age‐dependent changes in circulating extracellular vesicle cargo and function (2020) (55)
Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical Trial (2017) (55)
Diltiazem cardioplegia. A balance of risk and benefit. (1986) (54)
Improving myocardial metabolic and functional recovery after cardioplegic arrest. (1988) (54)
Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation. (2002) (54)
Cell transplantation preserves matrix homeostasis: a novel paracrine mechanism. (2005) (52)
Reducing the risk of urgent revascularization for unstable angina: a randomized clinical trial. (1986) (51)
A self-doping conductive polymer hydrogel that can restore electrical impulse propagation at myocardial infarct to prevent cardiac arrhythmia and preserve ventricular function. (2019) (51)
Improved myocardial performance following high 2-3 diphosphoglycerate red cell transfusions. (1975) (51)
Cardiac Metabolism and Performance Following Cold Potassium Cardioplegia (1978) (51)
Cell transplantation to prevent heart failure: a comparison of cell types. (2003) (50)
Late hemodynamic effects of the preserved papillary muscles during mitral valve replacement. (1994) (50)
The insulin cardioplegia trial: myocardial protection for urgent coronary artery bypass grafting. (2002) (50)
Reoperative coronary bypass surgery: effect of patent grafts and retrograde cardioplegia. (2001) (50)
Vascular endothelial growth factor transgene expression in cell-transplanted hearts. (2004) (50)
Optimal postoperative volume loading. (1983) (50)
Progressive Aortic Dilation Is Regulated by miR-17-Associated miRNAs. (2016) (49)
Cardiac release of prostacyclin and thromboxane A2 during coronary revascularization. (1987) (49)
Enhanced IGF-1 expression improves smooth muscle cell engraftment after cell transplantation. (2004) (48)
Effects of anaesthetic induction on myocardial function and metabolism: a comparison of fentanyl, sufentanil and alfentanil (1988) (48)
Right ventricular function: a comparison between blood and crystalloid cardioplegia. (1987) (48)
Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold. (2010) (47)
Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting. (2007) (47)
Improved myocardial protection during a prolonged cross-clamp period. (1983) (47)
The use of MMP2 antibody-conjugated cationic microbubble to target the ischemic myocardium, enhance Timp3 gene transfection and improve cardiac function. (2014) (47)
Hemodynamic and myocardial metabolic consequences of PEEP. (1985) (46)
Improvement in cardiac function after bone marrow cell thearpy is associated with an increase in myocardial inflammation. (2009) (46)
Role of WNT/β-catenin signaling in rejuvenating myogenic differentiation of aged mesenchymal stem cells from cardiac patients. (2012) (46)
Co-culture with cardiomyocytes enhanced the myogenic conversion of mesenchymal stromal cells in a dose-dependent manner (2010) (45)
Aged human cells rejuvenated by cytokine enhancement of biomaterials for surgical ventricular restoration. (2012) (44)
Optimal flow rates for retrograde warm cardioplegia. (1994) (44)
Comparison of alternative cardioplegic techniques. (1983) (44)
Prolonged hypothermic cardiac storage with University of Wisconsin solution. An assessment with human cell cultures. (1991) (44)
Delayed myocardial metabolic recovery after blood cardioplegia. (1989) (44)
Adverse effects of transfusion therapy during abdominal aortic aneurysectomy. (1978) (44)
Reconstitution of aged bone marrow with young cells repopulates cardiac-resident bone marrow-derived progenitor cells and prevents cardiac dysfunction after a myocardial infarction. (2013) (44)
Regional overexpression of insulin-like growth factor-I and transforming growth factor-beta1 in the myocardium of patients with hypertrophic obstructive cardiomyopathy. (2002) (44)
The management of nonmalignant intrathoracic esophageal perforations. (1980) (43)
Increased endothelin-1 production in diabetic patients after cardioplegic arrest and reperfusion impairs coronary vascular reactivity: reversal by means of endothelin antagonism. (2002) (43)
Clinical applicability of preconditioning and postconditioning: the cardiothoracic surgeons's view. (2006) (42)
Enhanced cell transplantation: preventing apoptosis increases cell survival and ventricular function. (2006) (42)
Effect of vitamin E on human glutathione peroxidase (GSH-PX1) expression in cardiomyocytes. (1996) (42)
A Prospective Multi-Institutional Cohort Study of Mediastinal Infections After Cardiac Operations. (2017) (41)
Decreased postoperative myocardial fatty acid oxidation. (1988) (41)
The IMPACT-CABG trial: A multicenter, randomized clinical trial of CD133+ stem cell therapy during coronary artery bypass grafting for ischemic cardiomyopathy. (2016) (41)
Decreasing incidence of stroke during valvular surgery. (1998) (41)
Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation. (2021) (41)
Water-soluble antioxidant specificity against free radical injury using cultured human ventricular myocytes and fibroblasts and saphenous vein endothelial cells. (1990) (41)
Novel cardioprotective effects of pravastatin in human ventricular cardiomyocytes subjected to hypoxia and reoxygenation: beneficial effects of statins independent of endothelial cells. (2004) (41)
Interleukin-6 downregulation with mesenchymal stem cell differentiation results in loss of immunoprivilege (2013) (40)
Losartan ameliorates "upstream" pulmonary vein vasculopathy in a piglet model of pulmonary vein stenosis. (2014) (40)
Cardiac cell transplantation: closer to bedside. (2003) (40)
Cell therapy to repair broken hearts. (1998) (40)
Preconditioning human cardiomyocytes and endothelial cells. (1998) (40)
Optimal myocardial protection. (1978) (40)
Should the pericardium be closed routinely after heart operations? (1999) (39)
Changing pattern of valve surgery. (1996) (39)
Atrial activity during cardioplegia and postoperative arrhythmias. (1988) (39)
A comparison of nitroglycerin and nitroprusside: I. Treatment of postoperative hypertension. (1985) (39)
Randomized study of right ventricular function with intermittent warm or cold cardioplegia. (1996) (38)
Enhanced angiogenesis with multimodal cell-based gene therapy. (2007) (38)
Off-pump coronary artery bypass surgery: fundamentals for the clinical cardiologist. (2004) (37)
Prolonged hypothermic cardiac storage for transplantation. The effects on myocardial metabolism and mitochondrial function. (1992) (37)
Transplantation of cryopreserved cardiomyocytes. (2001) (37)
Blood conservation with membrane oxygenators and dipyridamole. (1987) (36)
Recipient age determines the cardiac functional improvement achieved by skeletal myoblast transplantation. (2007) (36)
Combined Procedure of Surgical Repair and Cell Transplantation for Left Ventricular Aneurysm: An Experimental Study (2002) (35)
c‐Kit Function Is Necessary for In Vitro Myogenic Differentiation of Bone Marrow Hematopoietic Cells (2009) (35)
Transfusion of 2,3 DPG-enriched red blood cells to improve cardiac function. (1978) (35)
Canopy 2 attenuates the transition from compensatory hypertrophy to dilated heart failure in hypertrophic cardiomyopathy. (2015) (35)
Effect of Adenosine-Regulating Agent Acadesine on Morbidity and Mortality Associated With Coronary Artery Bypass Grafting: The RED-CABG Randomized Controlled Trial (2013) (35)
Bioactive coating of decellularized vascular grafts with a temperature‐sensitive VEGF‐conjugated hydrogel accelerates autologous endothelialization in vivo (2018) (34)
Current status of cellular therapy for ischemic heart disease. (2005) (34)
The effect of moderate exercise training on oxygen uptake post-aortic/mitral valve surgery. (1995) (34)
Hydrogels modified with QHREDGS peptide support cardiomyocyte survival in vitro and after sub-cutaneous implantation (2010) (33)
Elastin overexpression by cell-based gene therapy preserves matrix and prevents cardiac dilation (2012) (33)
Microplegia during coronary artery bypass grafting was associated with less low cardiac output syndrome: a propensity-matched comparison. (2013) (32)
Atrial activity during cardioplegia and postoperative arrhythmias (1987) (32)
Adequate distribution of warm cardioplegic solution. (1995) (32)
Complications associated with use of the intra-aortic balloon pump. (1982) (31)
Myocardial aerobic metabolism is impaired in a cell culture model of cyanotic heart disease. (1998) (31)
Cell transplantation to improve ventricular function in the failing heart. (2003) (31)
Cardiac Dysfunction During Abdominal Aortic Operation: The Limitations of Pulmonary Wedge Pressures (1986) (31)
Insulin cardioplegia for elective coronary bypass surgery. (2000) (30)
Myocardial protection for coronary bypass grafting: the Toronto Hospital perspective. (1995) (30)
Method of culturing cardiomyocytes from human pediatric ventricular myocardium (1992) (30)
A secreted protein (Canopy 2, CNPY2) enhances angiogenesis and promotes smooth muscle cell migration and proliferation. (2015) (30)
Current risk of coronary bypass for unstable angina. (1991) (30)
A conductive cell-delivery construct as a bioengineered patch that can improve electrical propagation and synchronize cardiomyocyte contraction for heart repair. (2020) (30)
Mast cells promote proliferation and migration and inhibit differentiation of mesenchymal stem cells through PDGF. (2016) (30)
Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial. (2012) (30)
Antegrade and retrograde cardioplegia: alternate or simultaneous? (1996) (29)
L-arginine protects human heart cells from low-volume anoxia and reoxygenation. (2002) (29)
What's New in Cardiac Cell Therapy? Allogeneic Bone Marrow Stromal Cells as “Universal Donor Cells” (2010) (29)
Aged Human Multipotent Mesenchymal Stromal Cells Can Be Rejuvenated by Neuron-Derived Neurotrophic Factor and Improve Heart Function After Injury (2017) (29)
Optimized count-based scintigraphic left ventricular volume measurement. (1985) (29)
Transforming the promise of pluripotent stem cell-derived cardiomyocytes to a therapy: challenges and solutions for clinical trials. (2014) (29)
Postoperative hypertension: a comparison of diltiazem, nifedipine, and nitroprusside. (1988) (29)
Predictors of contemporary coronary artery bypass grafting outcomes. (2014) (29)
Donor blood perfusion improves myocardial recovery after heart transplantation. (1997) (28)
Combined endothelial and myocardial protection by endothelin antagonism enhances transplant allograft preservation. (2005) (28)
The conductive function of biopolymer corrects myocardial scar conduction blockage and resynchronizes contraction to prevent heart failure. (2020) (28)
Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival. (2007) (28)
Cell fusion contributes to the rescue of apoptotic cardiomyocytes by bone marrow cells (2012) (28)
Optimal myocardial preconditioning in a human model of ischemia and reperfusion. (1998) (28)
Reduced ischemic injury after stroke in mice by angiogenic gene delivery via ultrasound-targeted microbubble destruction. (2014) (27)
Mesenchymal stem cells engineered to overexpress stem cell factor improve cardiac function but have malignant potential. (2008) (27)
Transplantation of cryopreserved muscle cells in dilated cardiomyopathy: effects on left ventricular geometry and function. (2003) (27)
Antioxidation of human low density lipoprotein by morin hydrate. (1995) (27)
Myocardial perfusion during warm antegrade and retrograde cardioplegia: a contrast echo study. (1999) (27)
Myocardial Stunning After Coronary Bypass Surgery (1993) (27)
Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice. (2009) (27)
EXTUBATION AND MYOCARDIAL ISCHEMIA (1984) (27)
Vitamin E for coronary bypass operations (1994) (26)
Prevention of myocardial platelet deposition and thromboxane release with dipyridamole. (1986) (26)
Clinical Decision Making for Endovascular Repair of Abdominal Aortic Aneurysm (2004) (26)
The characterization and purification of a human transcription factor modulating the glutathione peroxidase gene in response to oxygen tension (2004) (26)
The determinants of mortality and morbidity after multiple-valve operations. (1987) (26)
Tissue-Engineered Grafts Matured in the Right Ventricular Outflow Tract (2004) (25)
Adenosine pretreatment for prolonged cardiac storage. An evaluation with St. Thomas' Hospital and University of Wisconsin solutions. (1995) (25)
Can the results of contemporary aortic valve replacement be improved? (1986) (25)
The independence of pulmonary shunting and pulmonary edema. (1973) (24)
Transplanted cardiomyocytes survive in scar tissue and improve heart function. (1997) (24)
Molecular structure and antioxidant specificity of purpurogallin in three types of human cardiovascular cells. (1996) (24)
Determinants of survival and valve failure after mitral valve replacement. (1990) (24)
Recent Preoperative Myocardial Infarction Increases the Risk of Surgery for Unstable Angina (1991) (24)
Emerging roles of extracellular vesicles in cardiac repair and rejuvenation. (2018) (24)
An in vitro model to study myocardial ischemic injury (1994) (24)
Prevention of postbypass bleeding with tranexamic acid and epsilon-aminocaproic acid. (1993) (22)
Ascending aorta to bifemoral bypass--a ventral aorta. (1986) (22)
Young Bone-Marrow Sca-1+ Stem Cells Rejuvenate the Aged Heart and Improve Function after Injury through PDGFRβ-Akt pathway (2017) (22)
Effects of cell-based angiogenic gene therapy at 6 months: persistent angiogenesis and absence of oncogenicity. (2007) (22)
The hemodynamic effects and mechanism of action of pulmonary artery balloon counterpulsation in the treatment of right ventricular failure during left heart bypass. (1985) (21)
An adult uterine hemangioblast: evidence for extramedullary self-renewal and clonal bilineage potential. (2010) (21)
Clinical and Doppler echocardiographic evaluation of bioprosthetic valve failure after 10 years. (1990) (21)
Right ventricular failure. Pathophysiology and treatment. (1985) (21)
Rewarming hypovolemia after aortocoronary bypass surgery (1984) (20)
Expression of CNPY2 in Mouse Tissues: Quantification and Localization (2014) (20)
Morin hydrate inhibits azo-initiator induced oxidation of human low density lipoprotein. (1995) (20)
Production and reversibility of right ventricular hypertrophy and right heart failure in dogs. (1992) (20)
Clinical applications of thermodilution cardiac output determinations. (1975) (20)
The Hemodynamic and Metabolic Response to Pacing After Aortocoronary Bypass (1981) (20)
Effect of orally administered alpha-tocopheryl acetate on human myocardial alpha-tocopherol levels (1991) (20)
Tetrahydrobiopterin deficiency exaggerates intimal hyperplasia after vascular injury. (2005) (20)
Preservation of conductive propagation after surgical repair of cardiac defects with a bio-engineered conductive patch. (2017) (19)
Transmyocardial Laser Revascularization: A Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) 2006 (2006) (19)
Restoration and regeneration of failing myocardium with cell transplantation and tissue engineering. (2003) (19)
Pulmonary artery balloon counterpulsation in the management of right heart failure during left heart bypass. (1985) (18)
The promise and challenges of cardiac stem cell therapy. (2014) (18)
Myocardial Protection in Reoperative Coronary Artery Bypass Grafting: (2004) (18)
Myocardial performance curves as guide to volume therapy. (1979) (18)
Vascular endothelial growth factor receptor upregulation in response to cell-based angiogenic gene therapy. (2005) (18)
Cell transplantation comes of age. (2001) (18)
Optimal flow rates for integrated cardioplegia. (1998) (18)
Non-invasive Macrophage Tracking Using Novel Porphysome Nanoparticles in the Post-myocardial Infarction Murine Heart (2016) (18)
Survival and bioprosthetic valve failure. Ten-year follow-up. (1989) (18)
Right ventricular function and metabolism. (1990) (18)
Myometrial cells induce angiogenesis and salvage damaged myocardium. (2006) (17)
The rejuvenation of aged stem cells for cardiac repair. (2014) (17)
Adenosine Myocardial Protection (1999) (17)
Cavopulmonary Support with a Microaxial Pump for the Failing Fontan Physiology (2015) (17)
A comparison of volume loading and atrial pacing following aortocoronary bypass. (1983) (17)
Stem cells for cardiac regeneration by cell therapy and myocardial tissue engineering. (2009) (16)
The American Association for Thoracic Surgery Consensus Guidelines: Reasons and purpose. (2016) (16)
CD34+ Stem Cells: Promising Roles in Cardiac Repair and Regeneration. (2019) (16)
Coronary artery bypass grafting in patients with non-dialysis-dependent renal insufficiency. Commentary (1997) (16)
Determinants of risk for coronary artery bypass grafting in stable and unstable angina pectoris. (1985) (16)
Stem cells in clinical practice. (2003) (15)
Long‐term repopulation of aged bone marrow stem cells using young Sca‐1 cells promotes aged heart rejuvenation (2019) (15)
Ischemic intervals during warm blood cardioplegia in the canine heart evaluated by phosphorus 31-magnetic resonance spectroscopy (1997) (15)
Dipyridamole reduced myocardial platelet and leukocyte deposition following ischemia and cardioplegia. (1987) (15)
Optimal conditions for heart cell cryopreservation for transplantation (2004) (15)
The American Association for Thoracic Surgery/Society of Thoracic Surgeons position statement on developing clinical practice documents. (2017) (15)
Thoracic aortic surgery. (1991) (14)
Oxyradical-induced antioxidant and lipid changes in cultured human cardiomyocytes. (1994) (14)
Uterine cells are recruited to the infarcted heart and improve cardiac outcomes in female rats. (2012) (14)
Models of Myocardial Stunning (1993) (14)
Late postoperative ventricular function after blood and crystalloid cardioplegia. (1986) (14)
Doppler Echocardiography Assessment of Prosthetic Heart Valves (1990) (14)
The MRL mouse heart does not recover ventricular function after a myocardial infarction. (2008) (14)
Caveolin: A key target for modulating nitric oxide availability in health and disease (2003) (14)
Gallium-67 scanning in the diagnosis of postoperative sternal osteomyelitis: concise communication. (1983) (13)
Assessment of mitral and tricuspid competence after valvuloplasty. (1983) (13)
Reloading the heart: a new animal model of left ventricular assist device removal. (2005) (13)
Cardiac storage with University of Wisconsin solution, calcium, and magnesium. (1995) (13)
Delineating the relationship between immune system aging and myogenesis in muscle repair (2020) (13)
Isolation of cardiomyocytes from human myocardium for primary cell culturing (1993) (13)
Results of represervation of the chordae tendineae during redo mitral valve replacement. (1996) (13)
Cardiac output measurement by thermodilution during cardiac operations. (1976) (13)
Transmyocardial Laser Revascularization: A Meta-Analysis and Systematic Review of Controlled Trials (2006) (13)
Young Bone Marrow Sca-1 Cells Rejuvenate the Aged Heart by Promoting Epithelial-to-Mesenchymal Transition (2018) (12)
The cardiac repair benefits of inflammation do not persist: evidence from mast cell implantation (2015) (12)
Cardiac storage with University of Wisconsin solution and a nucleoside-transport blocker. (1995) (12)
Cell transplantation in non-ischemic dilated cardiomyopathy. A novel biological approach for ventricular restoration. (2002) (12)
Future directions of vitamin E and its analogues in minimizing myocardial ischemia-reperfusion injury. (1993) (12)
Current concepts measurement of cardiac output by thermodilution. (1975) (12)
The risks in abdominal and thoracic surgery in COPD. (1973) (11)
Surgical treatment of annuloaortic ectasia. (1980) (11)
The effect of lactate infusion on myocardial metabolism and ventricular function following ischemia and cardioplegia. (1990) (11)
Young bone marrow Sca‐1 cells protect aged retina from ischaemia‐reperfusion injury through activation of FGF2 (2018) (11)
Improved myocardial protection with blood and crystalloid cardioplegia. (1984) (11)
Diagnostic value of the portable chest x-ray technic in pulmonary edema. (1978) (11)
Novel mediators of aneurysm progression in bicuspid aortic valve disease. (2019) (10)
Smooth muscle cells transplantation is better than heart cells transplantation for improvement of heart function in dilated cardiomyopathy. (2002) (10)
Is Blood Superior to Crystalloid Cardioplegia ? (2006) (10)
Considering Cause and Effect of Immune Cell Aging on Cardiac Repair after Myocardial Infarction (2020) (10)
Cultured vascular endothelial cell susceptibility to extracellularly generated oxidant injury. (1992) (10)
Does Ischemic Preconditioning Afford Clinically Relevant Cardioprotection? (2003) (10)
Angiogenesis: protein, gene, or cell therapy? (2001) (9)
Uterine-derived progenitor cells are immunoprivileged and effectively improve cardiac regeneration when used for cell therapy. (2015) (9)
Prolonged preservation with University of Wisconsin Solution. (1991) (9)
Effects of anesthetic induction on myocardial function and metabolism: a comparison of fentanyl, sufentanil and alfentanil. (1988) (9)
Rectification of radiotherapy-induced cognitive impairments in aged mice by reconstituted Sca-1+ stem cells from young donors (2020) (9)
The influence of risk on the results of warm heart surgery: a substudy of a randomized trial. (1997) (9)
Cardioplegia for severe coronary artery disease: an improved technique using direct coronary artery infusion. (1982) (8)
Aprotinin and dipyridamole for the safe reduction of postoperative blood loss. (1998) (8)
Effects of metabolic stimulation on cardiac allograft recovery. (2001) (8)
Cardiac Cell Transplantation (1995) (8)
Heart cell implantation after myocardial infarction (2005) (8)
Cardiac storage with UW solution and glucose. (1994) (8)
Knock‐out of MicroRNA 145 impairs cardiac fibroblast function and wound healing post‐myocardial infarction (2020) (8)
Indicator dilution measurements of lung volumes and alveolar air exchange during breathing. (1973) (7)
The limits of cardiac preservation with University of Wisconsin solution. (1991) (7)
Transluminal dilatation in the treatment of peripheral arterial occlusive disease. (1980) (7)
A comparison of nitroglycerin and nitroprusside: II. The effects of volume loading. (1985) (7)
Coenzyme Q(10) and congestive heart failure: what is the verdict? (2002) (7)
Radiochemical quantitation of conjugated dienes during ischemia and reperfusion in the rat liver. (1991) (7)
Endocardial excision versus encircling endocardial ventriculotomy. A comparison of effects on ventricular structure and function. (1986) (7)
Dual roles for bone marrow‐derived Sca‐1 cells in cardiac function (2017) (7)
Preservation of heart function in diabetic rats by the combined effects of muscle cell implantation and insulin therapy (2008) (7)
Dipyridamole for coronary artery bypass surgery. (1990) (7)
Oxygen transport function of preserved red blood cells and myocardial performance. (1978) (7)
Effects of butanedione monoxime and temperature on prolonged cardiac storage. (1997) (6)
A comparison of diltiazem, esmolol, nifedipine and nitroprusside therapy of post-CABG hypertension. (1990) (6)
Cell transplantation for heart disease: the clinical perspective. (2005) (6)
Transatlantic editorial on transcatheter aortic valve replacement. (2017) (6)
Limitations of portable roentgenography of the chest in patients with acute respiratory failure. (1978) (6)
Blood or crystalloid cardioplegia: which is better? (2013) (6)
16 – Bone Marrow Stem Cells: Properties and Pluripotency (2008) (6)
Polarized light based birefringence measurements for monitoring myocardial regeneration (2009) (6)
Joint statement on redundant (duplicate) publication by the Editors of the undersigned cardio-thoracic journals* (2015) (6)
Joint statement on redundant (duplicate) publication by the Editors of the undersigned cardiothoracic journals. (2015) (6)
Effect of intracoronary nitroglycerin on myocardial blood flow and distribution in pacing-induced angina pectoris. Quantitative assessment by single-photon emission tomography. (1985) (6)
Spirometry and the mechanisms of pulmonary complications following elective surgery. (1975) (6)
The Cardiothoracic Surgical Trials Network: Implications for clinical practice. (2017) (5)
Uterine-derived stem cells reconstitute the bone marrow of irradiated mice. (2015) (5)
Transatlantic Editorial on Transcatheter Aortic Valve Replacement. (2017) (5)
Cardiovascular tissue engineering therapy: so near, so far? (2005) (5)
Cardiac restoration by cell transplantation. (2004) (5)
Preconditioning to Improve Myocardial Protection a (1996) (5)
Aortic valve malformations and pulmonary autograft root dilatation. (2002) (5)
Surgical Reperfusion of Acute Myocardial Ischemia: A Clinical Review (1986) (5)
The American Association for Thoracic Surgery/Society of Thoracic Surgeons Position Statement on Developing Clinical Practice Documents. (2017) (5)
Comprehensive Evaluation of Ventricular Function During Physiological Pacing (1983) (5)
Survival and valve failure after aortic valve replacement. (1991) (5)
The effects of chordal preservation in ventricular function after mitral valve replacement (1990) (4)
The Use of Glucose and Insulin during Hypothermic and Normothermic CABG a (1996) (4)
New format for the Journal. (2017) (4)
Joint statement on redundant (duplicate) publication by the Editors of the undersigned cardio-thoracic journals. (2015) (4)
Synthesis of aliphatic polyester hydrogel for cardiac tissue engineering. (2014) (4)
Comparison of two experimental models for assessment of cardiac preservation. (1993) (4)
Validation of left ventricular function parameters acquired with the non-imaging nuclear probe: comparison with tantalum marker cine-fluoroscopy. (1990) (4)
Ascending aorta to bifemoral bypass[mdash ]a ventral aorta (1986) (4)
Improving donor heart preservation. (2012) (4)
Extracorporeal circulatory assist devices. (1987) (4)
Transatlantic Editorial on transcatheter aortic valve replacement. (2017) (4)
Knockout of Canopy 2 activates p16INK4a pathway to impair cardiac repair. (2019) (4)
Volume loading and nitroprusside in abdominal aortic aneurysectomy. (1978) (4)
The results of cardiac valve procedures. (1993) (3)
THE EFFECTS OF FENTANYL AND ITS ANALOGUES (SUFENTANIL AND ALFENTANIL) ON VENTRICULAR FUNCTION (1984) (3)
Guidelines for Reporting Morbidity and Mortality after Cardiac Valvular Operations (1996) (3)
Reduction of post cardiopulmonary bypass bleeding with tranexamic acid (1992) (3)
Back to the bench: The rejuvenation of stem cell therapy--the therapeutic potential of CD133(+) progenitor cells. (2010) (3)
Modulation of Alloimmune Responses by Interleukin-10 Prevents Rejection of Implanted Allogeneic Smooth Muscle Cells and Restores Postinfarction Ventricular Function (2015) (3)
Shunting in the lung: a two-compartment model. (1972) (3)
Optimizing cardiac cell therapy: from processing to delivery. (2005) (3)
Turbid polarimetry for tissue characterization (2009) (3)
Tissue-engineered grafts matured in the right ventricular outflow tract. (2004) (3)
Managing conflicts of interest. (2015) (3)
Platelet Dysfunction after Coronary Artery Bypass Surgery (1991) (3)
P50 determinations: techniques and clinical importance. (1973) (3)
Cost-effective provision of cardiac services in a fixed-dollar environment. (1996) (3)
Cell transplantation, ventricular remodeling, and the extracellular matrix (2002) (3)
COMPARISON OF DILTIAZEM, NIFEDIPINE AND NITROPRUSSIDE IN THE TREATMENT OF POST-CARDIOPULMONARY BYPASS HYPERTENSION (1986) (2)
867-5 Rosiglitazone modulates angiogenic progenitor cell differentiation and attenuates intimal hyperplasia after vascular intervention (2004) (2)
The conclusion of papers published in the Journal should be supported by an appropriate statistical analysis. (2014) (2)
Treatment of acute respiratory insufficiency with cyclic expiratory pressure. (1973) (2)
Preoperative management of the patient with coronary artery disease before abdominal aortic surgery. (1987) (2)
Optimizing myocardial perfusion during coronary bypass—A contrast echo study (1995) (2)
The influence of risk on the results of warm heart surgery — a substudy from a randomized trial of 1732 patients (1995) (2)
Cardiac myocyte transplantation does not increase global epicardial repolarization heterogeneity in a rat infarct model. (2007) (2)
Cardiac Dysfunction During Abdominal Aortic Operation (1986) (2)
COMPARISON OF ESMOLOL, NIFEDIPINE AND NITROPRUSSIDE FOR TREATMENT OF POST ACB HYPERTENSION (1989) (2)
Aging impairs human bone marrow function and cardiac repair following myocardial infarction in a humanized chimeric mouse (2021) (2)
Cardiac restoration: frontier or fantasy? (2005) (2)
Calcium channel blockers in myocardial and cerebral ischemia: a clinician's review from bench to bedside. (1999) (2)
Right and left ventricular metabolites. (1988) (2)
Age-related defects in autophagy alter the secretion of paracrine factors from bone marrow mononuclear cells (2021) (2)
Tissue Engineering to Restore Cardiac Function (2021) (2)
Cyclosporin induced endothelial dysfunction: effects of the nitric oxide cofactor, tetrahydrobiopterin (2002) (1)
AN INJECTABLE CONDUCTIVE POLYMER HYDROGEL IMPROVES ELECTRICAL CONDUCTION VELOCITY IN THE INJURED HEART (2015) (1)
REWARMING HYPOVOLEMIA AFTER AORTOCORONARY BYPASS (1982) (1)
New features for the Journal (2014) (1)
Abstract 12913: microRNA-17 Targets TIMP-1 and TIMP-2 to Accelerate Cardiac Matrix Remodeling After Infarction (2011) (1)
180 microrna-17 Accelerates Cardiac Matrix Remodeling After Myocardial Infarction by Targeting Timp-1 and Timp-2 (2011) (1)
Adenosine cardioplegia and myocardial metabolism (1998) (1)
Abstract 11375: miR-145 Is a Key Regulator of Cardiac Myofibroblast Differentiation (2012) (1)
The Operating Room as a Laboratory (1998) (1)
Journal changes and initiatives. (2016) (1)
Cell transplantation: back to the bench: introduction. (2008) (1)
Tissue Engineering Applications for Cardiovascular Substitutes (2009) (1)
Abstract 2892: Inhibition of Toll-like Receptor-2 May Limit Cardiac Dysfunction After a Myocardial Infarction by Reducing Apoptosis via a p38 MAPK-dependent Pathway (2007) (1)
Ventricular Function Following Mitral Valve Replacement (1985) (1)
Transient biventricular dysfunction following coronary bypass surgery with potassium cardioplegia. (1987) (1)
Uterine-Derived CD11b Cells Significantly Increase Vasculogenesis and Promote Myocardial Healing in Ischemic Cardiomyopathy (2016) (1)
D011 Mesenchymal stem cells engineered to overexpress stem cell factor improve cardiac function but have malignant potential (2009) (1)
Abstract 2043: Bone Marrow Mesenchymal Stem Cells Acquire a Cardiogenic Phenotype via Transdifferentiation and Cell Fusion with Cardiomyocytes (2006) (1)
Abstract 861: Post Myocardial Infarction Implantation of Mesenchymal Stem Cells Engineered to Over-express Stem Cell Factor Improves Cardiac Function but Results in Tumorogenesis (2007) (1)
Improving myocardial metabolism and ventricular function following cardioplegia and reperfusion (1986) (1)
Is atrial function affected by conventional cardioplegic arrest? (1985) (1)
Abstract 1478: Angiogenesis After a Myocardial Infarction is Regulated by Bone Marrow c-kit+ Cells (2006) (1)
ADVERSE MYOCARDIAL FUNCTION AND METABOLISM ON ANESTHETIC INDUCTION: A COMPARISON OF FENTANYL, SUFENTANIL AND ALFENTANIL. (1986) (1)
Introduction: Great Institutions in Cardiothoracic Surgery. (2015) (1)
Cell transplantation as a novel therapy for congestive heart failure (2000) (1)
Changing patterns of intra-aortic balloon pump assistance. (1978) (1)
PEEP PRODUCES CARDIAC ISCHEMIA (1982) (1)
Mechanical Support of the Failing Right Ventricle (1987) (1)
Abstract 4743: Angiogenic Cytokine-conjugated Injectable Hydrogel Stabilized a Cardiac Infarct, Increased Blood Vessel Density and Improved Function (2009) (1)
REPETITIVE TARGETED DELIVERY OF GDF11 BY ULTRASOUND-MEDIATED CATIONIC MICROBUBBLE DESTRUCTION REJUVENATES AND PROTECTS THE AGED MOUSE HEART (2015) (1)
Defining neuropsychological impairment: should we abandon the “20% of tests” rule? (2002) (1)
Abstract 4296: Allogeneic Bone Marrow Mesenchymal Cells Improved Heart Function but Were Rejected after Myogenic Differentiation (2008) (1)
Expanding opportunities to publish in American Association for Thoracic Surgery journals. (2020) (1)
What to read? (2021) (1)
Acute pulmonary insufficiency following abdominal aortic aneurysm repair. (1977) (1)
Inaugural editorial: Communication (2014) (1)
Peri-operative supplemental warming was associated with fewer morbid cardiac events than routine thermal care. (1997) (1)
New developments for AATS publications. (2019) (1)
Pericardial graft for intraoperative balloon pump insertion. (1982) (1)
COMPUTATIONAL FLUID DYNAMICS MODELS OF HEALTHY AND FAILING FONTAN CIRCULATIONS (2015) (0)
Abstract 13072: Bone Marrow Reconstitution Restores Cardiac-Resident Stem Cells and Enhances Cardiac Repair after Infarction (2011) (0)
Adult cardiac surgery mortality and morbidity program (1990) (0)
Abstract 12299: Rejuvenation of the Bone Marrow-Derived Cardiac Resident Sca-1+ Stem Cell Subset Improved Healing of the Aged Heart (2015) (0)
artery bypass grafting The Insulin Cardioplegia Trial: Myocardial protection for urgent coronary (2013) (0)
A Comparison of Nitroglycerin and Nitroprusside: I. Treatment of Postoperative Hypertension (1985) (0)
Cardiac Surgery for Cardiogenic Shock (1988) (0)
Cardiac cell and gene transfer: principles, protocols and applications: Edited by Joseph M. Metzger, MD, 2003, Totowa, NJ, Humana Press, 260 pp, illustrated, $110.00, ISBN: 0-89603-994-3 (2003) (0)
AJP: Regulatory, Integrative and Comparative Physiology 1 TETRAHYDROBIOPTERIN DEFICIENCY EXAGGERATES INTIMAL HYPERPLASIAAFTER VASCULAR INJURY (2005) (0)
Mast Cell Granulates Suppress MSC Myogenic Differentiation Through MIR-145 and Promote Proliferation (2013) (0)
Abstract 16139: Mast Cells Promote Proliferation and Suppress Myogenic Differentiation of Mesenchymal Stem Cells (2015) (0)
The Use of Bone Marrow Mesenchymal Stem Cells to Repair the Infarcted Heart (2003) (0)
Myocardial aerobic metabolism is impaired in a cell culture model of cyanotic heart disease. (1998) (0)
Should edge-to-edge fixation be routine? (2016) (0)
Intraoperative atrial protection (reviewers comments) (1986) (0)
Does Lethal Reperfusion Injury Exist in Cardiac Surgery? (2004) (0)
Abstract 18248: Reduced {beta}-catenin Expression in Mouse Cardiomyocytes Increases Matrix Metalloproteinase Activation and Apoptosis, Producing Greater Post-Infarction Ventricular Dysfunction (2013) (0)
Abstract 16588: A Conductive Biomaterial Patch to Repair a Cardiac Defect (2016) (0)
An improved cardioplegic technique (1982) (0)
Abstract 4300: Cells and Cytokines Induce Regeneration after Cardiac Repair with a New Biodegradable Scaffold (2008) (0)
519 PGE2 Preserved Immune Privilege of Allogeneic Mesenchymal Stem Cells and Restored Post-Infarction Ventricular Function (2012) (0)
C-reactive protein activates the NF-κB signal transduction pathway in human saphenous vein endothelial cells (2003) (0)
Hemodynamicand MyocardialMetabolic Consequencesof PEEP (2015) (0)
251-256; SA Oct02 Cardio (2002) (0)
NORMOVOLEMIC ANEMIA REDUCES CARDIAC RESERVE (1982) (0)
Farewell editorial. (2021) (0)
Abstract 16540: MicroRNA 145 Prevents Infarct Scar Expansion and May be a New Target for Cardiac Restoration After Myocardial Infarction (2016) (0)
A COMPARISON OF ANESTHETIC TECHNIQUES FOR AORTIC RECONSTRUCTIVE SURGERY (1984) (0)
Abstract 15350: Progressive Aortic Dilatation is Regulated by the mir-17 Cluster (2014) (0)
Intraoperative myocardial protection: current perspectives and future trends (2004) (0)
Young Bone Marrow Sca-1 Cells Rejuvenate the Aged Heart by Promoting Epithelial-to-Mesenchymal Transition: Erratum (2023) (0)
On “Acute Effect of Cerivastatin on Cardiac Regional Ischemia in a Rat Model Mimicking Off‐pump Coronary Surgery” (2005) (0)
Making for Endovascular Repair of Abdominal Aortic Aneurysm (2004) (0)
Commentary: Trust but verify-How do we keep the faith? (2019) (0)
Abstract 16576: Young Bone Marrow Sca-1 Cells Rejuvenate the Aged Heart by Promoting Epithelial-to-Mesenchymal Transition (2016) (0)
PAN-CANADIAN SURVEY OF MODELS OF CARE OF PATIENTS WITH THORACIC AORTIC DISEASE (2016) (0)
Abstract 16640: Conductive Biomaterial Enhanced Electrical Propagation Across a Left Ventricular Scar After a Myocardial Infarction (2016) (0)
Grafts for myocardial scars, as well as method and cellular preparations for (1998) (0)
KNOCK-OUT OF CANOPY 2 ACTIVATES P16 PATHWAY TO IMPAIR CARDIAC REGENERATION (2016) (0)
Angiogenesis by means of endothelial cell transplantation. Authors' reply (2003) (0)
Grafting: Results of the EXPEDITION Study Ischemic Cardiac Events in Patients Undergoing Coronary Artery Bypass Sodium-Hydrogen Exchange Inhibition by Cariporide to Reduce the Risk of (2013) (0)
The limits of cardiac preservation with University of Wisconsin Solution (1990) (0)
CONSEQUENCES OF POSTOPERATIVE ALTERATIONS IN RESPIRATORY MECHANICS (1975) (0)
CONDUCTIVE BIOMATERIAL ENHANCED ELECTRICAL PROPAGATION OF LEFT VENTRICULAR SCAR TO ATTENUATE VENTRICULAR ARRHYTHMIA (2016) (0)
malformations: implications for aortic dilatation Vascular matrix remodeling in patients with bicuspid aortic valve (2013) (0)
The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events trial: To continue or not? How to answer the question. (2019) (0)
Cell therapy for ventricular dysfunction (2000) (0)
Grafts for myocardial scar (1999) (0)
Evaluation of Bioprosthetic Valve Failure After 10 Years (2005) (0)
Abstract 1858: Cardiac Engraftment and Distribution of Bone Marrow Stem Cells Implanted by Intravenous, Intracoronary and Intramyocardial Injections Using Molecular Imaging (2007) (0)
Abstract 378: In Vivo Gene Delivery by Ultrasound Targeted Microbubble Destruction Induces Angiogenesis and Benefits Cardiac Function after a Myocardial Infarction (2006) (0)
Mesenchymal Stem Cells and Restores Postinfarction Ventricular Function Preserving Prostaglandin E 2 Level Prevents Rejection of Implanted Allogeneic (2013) (0)
CONTROL OF POSTOPERATIVE HYPERTENSION - EFFECT ON HEMODYNAMICS AND CARDIAC METABOLIS (1982) (0)
Does the internal thoracic artery graft delay the recovery of myocardial metabolism? (1996) (0)
Effects of Postoperative Hypotension and Its Treatment (1984) (0)
Abstract 13988: Class II Major Histocompatibility Complex Transactivator (CIITA) Knockdown Prevents Immune Rejection of Allogeneic Bone Marrow Stem Cells in Cardiac Regeneration (2014) (0)
A novel technique to assess flow-mediated vasodilation. (2004) (0)
Novel cardioprotective effects of tetrahydrobiopterin (BH4) following ischemia reperfusion (I/R) (2001) (0)
Superior preservation using University of Wisconsin Solution (1990) (0)
Abstracts from the 32nd Annual Meeting of the Society of Thoracic Surgeons Orlando, Florida, USA January 29–31, 1996 (1996) (0)
Optimizing Stem Cell Therapy for Cardiac Repair Following a Myocardial Infarction (2013) (0)
Cardiac cell therapy to restore contracting elements (2014) (0)
Iconographies supplémentaires de l'article : Stem cells in clinical practice (2011) (0)
L-arginine protects human heart cells from simulated anoxia and reoxgenation (2002) (0)
Abstract P013: Canopy 2 Encodes for a Novel Secreted Proangiogenic Factor that Revascularizes and Regenerates Murine Hearts Post Myocardial Infarction (2011) (0)
398 Enhanced in vivo cardiac tissue formation by cyclic stretching of patches seeded with human embryonic stem cell-derived cardiomyocytes (2011) (0)
Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle (2003) (0)
Abstract 2673: Myoblast Transplantation Improves Cardiac Function Whether the Cells are Implanted Early or Late After Coronary Ligation (2007) (0)
Myocardial protective techniques used at the University of Toronto for coronary artery bypass surgery: Past, present and future (1994) (0)
VALVUIAR HEART DISEASE (2005) (0)
Abstract 1604: Improved Cardiac Function after Expression of the Human Elastin Gene in the Infarcted Myocardium (2008) (0)
A process for the preparation of mesenchymal stem cells (1999) (0)
YOUNG BONE MARROW SCA-1 CELLS REJUVENATE AGED HEART TO ENHANCE CARDIAC REPAIR BY PROMOTING EPITHELIAL-TO-MESENCHYMAL TRANSITION THROUGH TGF-β SIGNALING (2016) (0)
Introduction: Great Institutions in Cardiothoracic Surgery, Adding to the List. (2020) (0)
Abstract 16485: Reconstitution of Aged Bone Marrow With Young Sca-1 Cell Rejuvenates the Aged Heart (2017) (0)
Abstract 15288: Conductive Polymer Hydrogel for Enhancement of Electrical Propagation in Border Zone Myocardium after Myocardial Infarction (2014) (0)
Monitoring and improving patient safety during and following cardiac surgery : Monitoring and improving patient safety during and following cardiac surgery (2001) (0)
A CONDUCTIVE BIOMATERIAL PATCH FOR CARDIAC DEFECT REPAIR (2016) (0)
Abstract 11282: Maintaining Prostaglandin E2 Levels Prevents Rejection of Implanted Allogeneic Mesenchymal Stem Cells and Restores Post-Infarction Ventricular Function (2012) (0)
Young bone marrow Sca-1+ stem cells home to aged retina and protect retina from acute glaucoma injury (2016) (0)
Characterization of transcriptional regulation of myocardial gluthathione peroxidase activity (2001) (0)
PRESERVING IMMUNOPRIVILEGE OF ALLOGENEIC STEM CELLS FOR CARDIAC REGENERATION - ROLE OF CLASS II MAJOR HISTOCOMPATIBITY COMPLEX TRANSACTIVATOR (2014) (0)
Bosentan: a therapeutic strategy for severe radial artery vasospasm (2002) (0)
Using the Operating Room as a Laboratory (1991) (0)
C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and Function Further Evidence of a Mechanistic Link Between C-Reactive Protein and Cardiovascular Disease Clinical Investigation and Reports (2004) (0)
perfusionist interventions Cerebral microemboli during cardiopulmonary bypass: increased emboli during (2013) (0)
SF-050-1 Anti-apoptotic Strategy for Cell Transplantation : Comparison of Two Pre-treatment Methods (2007) (0)
Introduction to the 2016 Aortic Symposium Supplement. (2017) (0)
Agents that modify haemostasis after cardiopulmonary bypass (1993) (0)
Abstract 3548: Biodegradable Collagen Patch with Covalently Bound VEGF Improves Right Ventricular Repair (2008) (0)
nomenclature Inaccurate and misleading valve sizing: a proposed standard for valve size (2013) (0)
Preconditioning versus brain death in clinical transplantation. (2000) (0)
577 Aged Cardiac Patients Show Impaired Mesenchymal Stem Cell Differentiation to a Myogenic Phenotype Due to Depressed WNT/β-Catenin Signaling (2012) (0)
Reply: To PMID 23608252. (2014) (0)
Revisions to information for authors (2015) (0)
LEFT VENTRICULAR SYSTOLIC AND DIASTOLIC FUNCTION (BY PRESSURE/VOLUME LOOPS) DURING TREATMENT OF POST CABG HYPERTENSION (1991) (0)
Statistical report generation from a cardiac surgery database (1990) (0)
A long‐term efficacy of allogeneic bone marrow mesenchymal stem cells in myocardial repair (2011) (0)
Gallium-67ScanningintheDiagnosisof Postoperative SternalOsteomyelitis: ConciseCommunication (2006) (0)
Are patients with ventricular dysfunction more tolerant to ischemia (2005) (0)
C-reactive protein directly attenuates nitric oxide release and bioactivity (2003) (0)
TEMPORAL AND REGIONAL KINETICS OF THE POST-MYOCARDIAL INFARCTION MACROPHAGE RESPONSE: A NOVEL NANOPARTICLE TRACKING TECHNIQUE (2015) (0)
195 Uterine stem cells are recruited to the infarcted myocardium for cardiac regeneration (2011) (0)
576 Controlled Release of VEGF in the Infarct Region: Epicardial Implantation of a Microsphere-Loaded Patch (2012) (0)
Abstract 15547: Restoration of Interleukin-10 Levels in Differentiated Mesenchymal Stem Cells Preserves their Immunoprivilege in Allogeneic Implantation and Restores Post-Infarction Cardiac Function (2014) (0)
Invited commentary. (2004) (0)
A Pre-Clinical Animal Model of Mechanical Circulatory Support for Failing Single Ventricle Physiology: A Pilot Study (2013) (0)
THE IMPACT-CABG TRIAL: A CANADIAN RCT OF CD133+ STEM CELL THERAPY FOR ISCHEMIC CARDIOMYOPATHY (2015) (0)
401 Cardiac-resident bone marrow stem cells govern repair after infarction in aged mice (2011) (0)
406-2 Stem cell factor plays a critical role in neointimal formation by bone marrow derived progenitor cells (2004) (0)
Invited commentary. (2003) (0)
920-50 Do Females have the Same Risk Factors as Males for CABG? (1995) (0)
Abstract 16962: Two-year Outcomes Following Mitral Valve Repair or Replacement for Severe Ischemic Mitral Regurgitation (2015) (0)
Abstract 2879: Targeted and Tailored: A New Approach to Regeneration after a Myocardial Infarction (2008) (0)
MAST CELL TRANSPLANTATION IMPROVES INFARCT HEALING BUT DOES NOT RESTORE YOUTHFUL CARDIAC REGENERATION TO OLD MICE (2014) (0)
Introduction: Great Institutions in Cardiothoracic Surgery, Second Edition. (2016) (0)
Endothelial Progenitor Cells New Hope for a Broken Heart Brief Review: From Bench to Bedside (2003) (0)
Abstract 12453: Over-expression of NDNF Rejuvenates Aged Human Mesenchymal Stem Cells and Improves Mouse Heart Function After Myocardial Infarction (2015) (0)
Jostling with jargon. (2019) (0)
416: Rapamycin Attenuates Hypoxic Inhibition of Telomerase Activity in Endothelial Cells (2008) (0)
Cell transplantation in dilated cardiomyopathy preserved ventricular function (2001) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Richard D. Weisel?

Richard D. Weisel is affiliated with the following schools: